Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

205 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prediction of the chance of successful immune tolerance induction in persons with severe hemophilia A and inhibitors: a clinical prediction model.
Oomen I, Abdi A, Camelo RM, Callado FMRA, Carvalho LEM, Calcaterra IL, Carcao M, Castaman G, Eikenboom JCJ, Fischer K, Franco VKB, Heymans MW, Leebeek FWG, Lillicrap D, Lorenzato CS, Mancuso ME, Matino D, Di Minno MND, Mohseny AB, Oldenburg J, Rezende SM, Rivard GE, Rydz N, Schols SEM, Voorberg J, Fijnvandraat K, Gouw SC; International Genetic and clinical determinants for the outcome of immune tolerance induction study group. Oomen I, et al. Among authors: mancuso me. Res Pract Thromb Haemost. 2024 Oct 3;8(7):102580. doi: 10.1016/j.rpth.2024.102580. eCollection 2024 Oct. Res Pract Thromb Haemost. 2024. PMID: 39558913 Free PMC article.
Future needs for continuing innovation in hemophilia: improving outcomes for individuals of all severities, including women and those in resource-constrained regions.
Blatný J, Astermark J, Catarino C, Dolan G, Fijnvandraat K, Hermans C, Holstein K, Jiménez-Yuste V, Klamroth R, Lavin M, Lenting PJ, Lobet S, Mancuso ME, Motwani J, O'Donnell JS, Königs C. Blatný J, et al. Among authors: mancuso me. Ther Adv Hematol. 2024 Sep 30;15:20406207241285143. doi: 10.1177/20406207241285143. eCollection 2024. Ther Adv Hematol. 2024. PMID: 39381602 Free PMC article. Review.
Pharmacokinetics of Efmoroctocog alfa by Two-Compartment Model Highlights Hemophilia A Patients with Biphasic Decay, Long Mean Residence Time, and Beta Half-Life.
Morfini M, Peyvandi F, Mancuso ME, Marchesini E, Tagliaferri A, Gualtierotti R, Castaman G, Pollio B, Santoro C, Banov L, Napolitano M, Preti PS, Santoro RC, Coppola A, Linari S, Santagostino E, Bernardi F. Morfini M, et al. Among authors: mancuso me. J Clin Med. 2024 Aug 23;13(17):4986. doi: 10.3390/jcm13174986. J Clin Med. 2024. PMID: 39274196 Free PMC article.
The association between unemployment and treatment among adults with hemophilia.
Qvigstad C, Sørensen LQ, Tjønnfjord GE, Holme PA; Age-related DeVelopments ANd ComorbiditiEs in hemophilia Working Group. Qvigstad C, et al. Res Pract Thromb Haemost. 2024 Jul 14;8(5):102514. doi: 10.1016/j.rpth.2024.102514. eCollection 2024 Jul. Res Pract Thromb Haemost. 2024. PMID: 39188890 Free PMC article.
Damoctocog Alfa Pegol, a PEGylated B-domain Deleted Recombinant Extended Half-life Factor VIII for the Treatment of Hemophilia A: A Product Review.
Reding MT, Lalezari S, Kenet G, Di Minno G, Ducore J, Solms A, Shah A, Holme PA, Poulsen LH, Meijer K, Simpson M, Mancuso ME. Reding MT, et al. Among authors: mancuso me. Drugs R D. 2024 Sep;24(3):359-381. doi: 10.1007/s40268-024-00481-7. Epub 2024 Aug 20. Drugs R D. 2024. PMID: 39162954 Free PMC article. Review.
205 results